Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02782715 · ClinicalTrials.gov registry record · Phase 1
Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma
A Phase 1 study, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- Phase 1
- Development phase
- 3
- Enrollment target
NCT02782715 is a Phase 1 study that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 3 participants.
The verdict
NCT02782715, a Phase 1 study, was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 3 participants
- Enrollment target
Study Summary
The specific aims of this study are: 1. To determine the safety and feasibility of treating patients with a combination of MRI guided stereotactic body radiation therapy and microwave ablation. 2. To assess short and long-term toxicity rates of patients treated with a combined modality approach. 3. To assess local control, survival, and pathologic response to treatment
Interventions
- RADIATION Stereotactic Body Radiation Therapy (SBRT)
- PROCEDURE Microwave Ablation (MWA)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3 participants |
| Start Date | 2018-06-28 |
| Est. Completion | 2023-01-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02782715
The ClinicalTrials.gov registry entry for NCT02782715 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 3 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Stereotactic Body Radiation Therapy (SBRT) is the first listed.
NCT02782715 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02782715 about?
NCT02782715 is a clinical study titled "Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma". The specific aims of this study are: 1. To determine the safety and feasibility of treating patients with a combination of MRI guided stereotactic body radiation therapy and microwave ablation. 2. To assess short and long-term toxicity rates of patients treated with a combined modality approach. 3....
What is the current status of trial NCT02782715?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 3 participants. The study started on 2018-06-28. Estimated completion is 2023-01-10.
What interventions are being tested in trial NCT02782715?
The interventions under investigation include: Stereotactic Body Radiation Therapy (SBRT) (RADIATION), Microwave Ablation (MWA) (PROCEDURE).
Who is sponsoring clinical trial NCT02782715?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.